{
    "SPADE_UN_13555": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13555",
            "Peptide Name": "IBP02V4",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "ELSGINASVVNLQKEIDRLNEVAKNLNESLIDLQEL",
            "Sequence Length": 36,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.34344868]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.3±0.02 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=18.6 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=15.2 nM);SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.1±0.02 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=29.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=26.3 nM);SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=63±1.7 nM);MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=22.4±2.2 nM);HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=66.3±3.1 nM);HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=502±24.2 nM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10 μM.",
            "Binding Target": "liposomes",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "PEG8-K(Chol)",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C173H294N48O61",
            "Mass": 4022.47,
            "PI": 4.25,
            "Net Charge": -4,
            "Hydrophobicity": -0.22,
            "Half Life": "Mammalian:1 hourYeast:30 minE.coli:>10 hour",
            "Comments": "The peptide is a fusion inhibitor against SARS-CoV-2.",
            "Literature": [
                {
                    "Title": "SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.",
                    "Pubmed ID": "34344868",
                    "Reference": "Signal Transduct Target Ther. 2021 Aug 3;6(1)294.",
                    "Author": "Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34344868"
                }
            ],
            "Frequent Amino Acids": "LEN",
            "Absent Amino Acids": "CFHMOPTUWY",
            "Basic Residues": 3,
            "Acidic Residues": 7,
            "Hydrophobic Residues": 15,
            "Polar Residues": 18,
            "Positive Residues": 3,
            "Negative Residues": 7,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_22274",
                    "Similarity": 1.0,
                    "Sequence": "KEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYVW"
                },
                {
                    "SPADE_ID": "SPADE_UN_13526",
                    "Similarity": 1.0,
                    "Sequence": "IDRLNEVAKNLNESLIDLQELGK"
                },
                {
                    "SPADE_ID": "SPADE_UN_22236",
                    "Similarity": 1.0,
                    "Sequence": "NEVAKNLNESLIDLQELGKYEQYIKWPWYVW"
                }
            ]
        }
    }
}